Citius Oncology CTOR
NASDAQ CTOR
$1.01 -0.04 (-3.81%)
At close: Sep 30, 2026 · 4:00 PM EDT

Citius Oncology (CTOR) Free Cash Flow (2023 - 2026)

Updated

Citius Oncology (CTOR) reported Free Cash Flow of -$2.71 million for fiscal Q3 2026 (quarter ended Jun 30, 2026).

Analysis

Citius Oncology (CTOR) Free Cash Flow (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Citius Oncology's Free Cash Flow came in at -$14.26 million; for FY2025 (ended Sep 30, 2025), it was -$5.49 million.

  • By fiscal year, Free Cash Flow came in at $126,353 in FY2024, -$601,304 in FY2023 and -$47,968 in FY2022.
  • The fiscal Q3 2026 figure ranks as the highest quarterly Free Cash Flow since fiscal Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.30 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.11 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 6.20 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 5.34 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.49 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.43 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 302.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.01 Bn
10 Citius Oncology 106.82 Mn 106.82 Mn 1.00 Mn -2.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.71 Mn
Mar 31, 2026 -3.83 Mn
Dec 31, 2025 -7.35 Mn
Jun 30, 2024 -366,106.00
Mar 31, 2024 -191,690.00
Jun 30, 2023 -100,256.00
Mar 31, 2023 -168,799.00
API Access

Citius Oncology Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=CTOR&period=max&api_key=YOUR_API_KEY